Share

January 06, 2009; 72 (1) Articles

Oral fingolimod (FTY720) in multiple sclerosis

Two-year results of a phase II extension study

P. O'Connor, G. Comi, X. Montalban, J. Antel, E. W. Radue, A. de Vera, H. Pohlmann, L. Kappos
First published January 2, 2009, DOI: https://doi.org/10.1212/01.wnl.0000338569.32367.3d
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1788

Share

Article Information

vol. 72 no. 1 73-79
DOI: 
https://doi.org/10.1212/01.wnl.0000338569.32367.3d
PubMed: 
19122034
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published January 2, 2009.
Copyright & Usage: 
© 2009

Author Disclosures

    1. P. O'Connor, MD,
    2. G. Comi, MD,
    3. X. Montalban, MD,
    4. J. Antel, MD,
    5. E. W. Radue, MD,
    6. A. de Vera, MD,
    7. H. Pohlmann, MSc,
    8. L. Kappos, MD and
    9. For the FTY720 D2201 Study Group*
  1. P. O'Connor, MD,
  2. G. Comi, MD,
  3. X. Montalban, MD,
  4. J. Antel, MD,
  5. E. W. Radue, MD,
  6. A. de Vera, MD,
  7. H. Pohlmann, MSc,
  8. L. Kappos, MD and
  9. For the FTY720 D2201 Study Group*
  1. From St. Michael's Hospital (P.O.), Toronto, ON, Canada; Ospedale San Raffaele (G.C.), Milan, Italy; University Hospital Edif. EUI (X.M.), Barcelona, Spain; Montreal Neurological Institute (J.A.), Montreal, QC, Canada; MS MRI Evaluation Centre (E.W.R.) and Neurology and Department of Biomedicine (L.K.), University Hospital, Basel; and Novartis Pharma AG (A.d.V., H.P.), Basel, Switzerland.
  1. Address correspondence and reprint requests to Dr. Paul O'Connor, St. Michael's Hospital, Toronto, ON, Canada oconnorp{at}smh.toronto.on.ca
View Full Text

Article usage

Article usage: January 2009 to May 2021

AbstractFullPdfSource
Jan 2009755136362Highwire
Feb 20091374489Highwire
Mar 20091242277Highwire
Apr 20091143444Highwire
May 2009991455Highwire
Jun 2009852156Highwire
Jul 20091081347Highwire
Aug 2009821243Highwire
Sep 2009881151Highwire
Oct 2009891846Highwire
Nov 2009871044Highwire
Dec 20091031539Highwire
Jan 20101431834Highwire
Feb 20101091128Highwire
Mar 20101121729Highwire
Apr 2010972527Highwire
May 20101312521Highwire
Jun 20101062320Highwire
Jul 2010821317Highwire
Aug 20101082126Highwire
Sep 20101493447Highwire
Oct 20101463649Highwire
Nov 201038811Highwire
Dec 20101793231Highwire
Jan 20111363025Highwire
Feb 20111552725Highwire
Mar 20111391522Highwire
Apr 2011102812Highwire
May 20111621923Highwire
Jun 2011801519Highwire
Jul 20117159Highwire
Aug 201116988Highwire
Sep 20112232122Highwire
Oct 201121958Highwire
Nov 201118346Highwire
Dec 201114425Highwire
Jan 201228834Highwire
Feb 201229123Highwire
Mar 2012332310Highwire
Apr 201223224Highwire
May 2012203611Highwire
Jun 201221049Highwire
Jul 201221146Highwire
Aug 201215032Highwire
Sep 201214021Highwire
Oct 201210088Highwire
Nov 20128026Highwire
Dec 20125344Highwire
Jan 20138169Highwire
Feb 20136856Highwire
Mar 20138313Highwire
Apr 20137467Highwire
May 20134065Highwire
Jun 20136345Highwire
Jul 20134733Highwire
Aug 20133866Highwire
Sep 20136934Highwire
Oct 20134324Highwire
Nov 20135421Highwire
Dec 20136874Highwire
Jan 20145126Highwire
Feb 20145765Highwire
Mar 20147244Highwire
Apr 20145924Highwire
May 20146033Highwire
Jun 20147934Highwire
Jul 20143721Highwire
Aug 20142644Highwire
Sep 20144721Highwire
Oct 20143211Highwire
Nov 20144647Highwire
Dec 20143844Highwire
Jan 20154023Highwire
Feb 20153766Highwire
Mar 20153977Highwire
Apr 20152962Highwire
May 20151822Highwire
Jun 20152443Highwire
Jul 20152033Highwire
Aug 20152112Highwire
Sep 20152122Highwire
Oct 20152031Highwire
Nov 20153212Highwire
Dec 20153501Highwire
Jan 20161922Highwire
Feb 20164443Highwire
Mar 20161722Highwire
Apr 20162521Highwire
May 20167111Highwire
Jun 20162331Highwire
Jul 20162522Highwire
Aug 20162100Highwire
Sep 20161902Highwire
Oct 20163332Highwire
Nov 20163001Highwire
Dec 20161721Highwire
Jan 20172134Highwire
Feb 20172800Highwire
Mar 20174500Highwire
Apr 20171533Highwire
May 20173321Highwire
Jun 20171534Highwire
Jul 20172013Highwire
Aug 20172553Highwire
Sep 20171531Highwire
Oct 20172283Highwire
Nov 20173321Highwire
Dec 20172610Highwire
Jan 20183921Highwire
Feb 20183552Highwire
Mar 20183410Highwire
Apr 20184521Highwire
May 20182301Highwire
Jun 20185201Highwire
Jul 20182500Highwire
Aug 20183830Highwire
Sep 20181700Highwire
Oct 20183012Highwire
Nov 20184011Highwire
Dec 20183233Highwire
Jan 20194211Highwire
Feb 20192700Highwire
Mar 20194711Highwire
Apr 20191700Highwire
May 20193104Highwire
Jun 20192000Highwire
Jul 20192586Highwire
Aug 20193101Highwire
Sep 20192510Highwire
Oct 20193587Highwire
Nov 20193712Highwire
Dec 20191813Highwire
Jan 20202904Highwire
Feb 20203556Highwire
Mar 20202100Highwire
Apr 20201702Highwire
May 20201215Highwire
Jun 20201822Highwire
Jul 20201400Highwire
Aug 20202600Highwire
Sep 202011614Highwire
Oct 202076124Highwire
Nov 20203210Highwire
Dec 20202511Highwire
Jan 20212810Highwire
Feb 2021330Highwire
Mar 20212331Highwire
Apr 20211911Highwire
May 20213230Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me